Albemarle Corporation

DB:AMC Stock Report

Market Cap: €12.2b

Albemarle Valuation

Is AMC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AMC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AMC (€103.98) is trading below our estimate of fair value (€247.1)

Significantly Below Fair Value: AMC is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for AMC?

Key metric: As AMC is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AMC. This is calculated by dividing AMC's market cap by their current revenue.
What is AMC's PS Ratio?
PS Ratio2x
SalesUS$6.50b
Market CapUS$12.74b

Price to Sales Ratio vs Peers

How does AMC's PS Ratio compare to its peers?

The above table shows the PS ratio for AMC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.4x
SY1 Symrise
3x5.5%€14.8b
1COV Covestro
0.8x4.3%€10.8b
EVK Evonik Industries
0.5x2.2%€8.2b
2NF Syensqo
1.1x4.2%€7.5b
AMC Albemarle
2x9.1%€12.7b

Price-To-Sales vs Peers: AMC is expensive based on its Price-To-Sales Ratio (2x) compared to the peer average (1.4x).

Price to Sales Ratio vs Industry

How does AMC's PS Ratio compare vs other companies in the DE Chemicals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
2HRA H&R GmbH KGaA
0.1x3.0%US$132.56m
NSAK OTI Greentech
0.03xn/aUS$594.62k
B7Y Byotrol
0.04xn/aUS$246.97k
No more companies available in this PS range
AMC 2.0xIndustry Avg. 1.0xNo. of Companies4PS00.40.81.21.62+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AMC is expensive based on its Price-To-Sales Ratio (2x) compared to the European Chemicals industry average (1x).

Price to Sales Ratio vs Fair Ratio

What is AMC's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AMC PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio2x
Fair PS Ratio0.3x

Price-To-Sales vs Fair Ratio: AMC is expensive based on its Price-To-Sales Ratio (2x) compared to the estimated Fair Price-To-Sales Ratio (0.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst AMC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€103.98
€109.87
+5.7%
29.3%€212.36€68.90n/a26
Nov ’25€88.09
€105.31
+19.5%
31.2%€208.44€67.63n/a26
Oct ’25€84.89
€100.29
+18.1%
32.4%€201.51€65.38n/a26
Sep ’25€81.25
€100.40
+23.6%
32.3%€201.17€65.27n/a26
Aug ’25€89.37
€117.51
+31.5%
27.0%€208.51€75.06n/a25
Jul ’25€89.83
€138.53
+54.2%
24.9%€256.60€75.58n/a24
Jun ’25€111.00
€142.07
+28.0%
24.3%€254.62€75.00n/a25
May ’25€113.02
€143.42
+26.9%
24.1%€258.80€76.23n/a27
Apr ’25€121.28
€138.41
+14.1%
25.1%€253.72€74.73n/a27
Mar ’25€131.60
€140.60
+6.8%
26.6%€276.84€83.05n/a27
Feb ’25€105.30
€149.38
+41.9%
25.2%€276.00€82.80n/a27
Jan ’25€135.16
€171.18
+26.6%
30.3%€279.94€81.80n/a27
Dec ’24€111.18
€175.31
+57.7%
30.2%€282.99€82.69n/a27
Nov ’24€114.98
€225.16
+95.8%
23.5%€330.72€146.46€88.0926
Oct ’24€163.76
€250.35
+52.9%
17.8%€331.07€146.61€84.8924
Sep ’24€185.52
€243.96
+31.5%
18.3%€322.60€142.86€81.2525
Aug ’24€190.00
€241.80
+27.3%
19.9%€325.44€140.12€89.3725
Jul ’24€205.00
€241.34
+17.7%
20.6%€330.12€142.14€89.8325
Jun ’24€182.96
€247.91
+35.5%
21.9%€336.85€145.03€111.0024
May ’24€168.04
€260.55
+55.1%
25.2%€453.93€141.28€113.0222
Apr ’24€202.65
€294.28
+45.2%
19.6%€459.11€142.89€121.2822
Mar ’24€235.85
€296.09
+25.5%
19.3%€467.07€145.37€131.6024
Feb ’24€259.20
€288.02
+11.1%
19.8%€457.19€142.58€105.3023
Jan ’24€202.85
€295.95
+45.9%
19.5%€434.22€145.99€135.1621
Dec ’23€266.85
€310.81
+16.5%
19.5%€446.16€150.01€111.1820
Nov ’23€288.20
€320.07
+11.1%
20.1%€449.72€148.20€114.9820

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Stanmore Resources

AU$2.8b

Engages in the exploration, development, production, and sale of metallurgical coal in Australia.

S0D

AU$1.91

7D

4.9%

1Y

-15.5%

Tokuyama

JP¥196.7b

Produces and sells various chemical products in Japan.

TBT

JP¥16.60

7D

5.7%

1Y

14.5%

Arkema

€5.7b

Manufactures and sells specialty chemicals and advanced materials worldwide.

V1S

€74.55

7D

-4.4%

1Y

-19.9%